insights_auto
Why is DFTX up 2.65%?
Dive Deeperchevron_right
DFTX:NASDAQ
Definium Therapeutics Inc
$40.32
arrow_upward
+2.65%(+1.04) 1D
$40.00
arrow_downward
-0.79% (-0.32)bedtimeAfter hours
Closed: Sep 22, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$39.42
High
$40.39
Low
$38.70
Mkt. cap
5.42B
Avg. vol.
2.32M
Volume
0.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
Open
$39.42
High
$40.39
Low
$38.70
Mkt. cap
5.42B
Avg. vol.
2.32M
Volume
0.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Simply Wall Street
·
3 days ago
Definium Therapeutics (DFTX) Posts Another Positive Phase 3, Is The Stock Still A Bargain?
Reuters
·
1 week ago
Definium's LSD-based anxiety, depression drug scores another trial win
Investor's Business Daily
·
1 week ago
Psychedelics Stock, Up 190% This Year, Flies High Again
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com